Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,326 | -8,074 | -5,797 | -3,313 | -1,644 |
| Depreciation Amortization | 8 | 16 | 9 | 674 | 3 |
| Accounts receivable | -9 | -27 | -42 | -5 | 14 |
| Other Working Capital | -186 | -189 | -139 | -35 | -119 |
| Other Operating Activity | 1,337 | 4,553 | 3,170 | 986 | 759 |
| Operating Cash Flow | $-1,176 | $-3,721 | $-2,799 | $-1,694 | $-987 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -62 | -55 | -6 | N/A |
| Investing Cash Flow | $N/A | $-62 | $-55 | $-6 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 300 | 3,107 | 2,490 | 835 | 255 |
| Common Stock Issued | 153 | 864 | 355 | N/A | N/A |
| Financing Cash Flow | $453 | $3,971 | $2,845 | $835 | $255 |
| Exchange Rate Effect | -11 | -41 | -22 | -10 | -9 |
| Beginning Cash Position | 1,910 | 1,763 | 1,763 | 1,763 | 1,763 |
| End Cash Position | 1,176 | 1,910 | 1,732 | 889 | 1,022 |
| Net Cash Flow | $-735 | $147 | $-31 | $-874 | $-741 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,176 | -3,721 | -2,799 | -1,694 | -987 |
| Capital Expenditure | N/A | -62 | -55 | -6 | N/A |
| Free Cash Flow | -1,176 | -3,783 | -2,854 | -1,699 | -987 |